Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT)

1.70
Delayed Data
As of 2:55pm ET
 -0.05 / -2.86%
Today’s Change
0.93
Today|||52-Week Range
2.45
+57.41%
Year-to-Date

Today’s Trading

Previous close1.75
Today’s open1.75
Day’s range1.69 - 1.79
Volume490,814
Average volume (3 months)419,889
Market cap$56.1M
Data as of 2:55pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+23.53%
Earnings growth (this year)-1.92%
Earnings growth (next 5 years)+0.00%
Revenue growth (last year)+365.37%
P/E ratioNM
Price/Sales8.02
Price/Book3.66

Competitors

 Today’s
change
Today’s
% change
AKTXAkari Therapeutics P...-0.03-1.50%
KMPHKemPharm Inc-0.10-1.64%
ALTAltimmune Inc-0.05-6.50%
HSGXHistogenics Corp-0.01-0.56%
Data as of 3:11pm ET, 04/20/2018

Financials

Next reporting dateMay 15, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$7.5M
Annual profit (last year)-$18.5M
Net profit margin-245.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nancy Sue Lurker
Vice President-
Operations
Marty Nazzaro
Corporate headquarters
Watertown, Massachusetts

Forecasts